Delivery Order SPE2DB22D2206-SPE2DB24FFQ98
Award Date 2/15/24
Potential Completion Date 3/8/24
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract, valued at $23,824.28, has an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,736.24, is for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a specialty medication. The contract has an ultimate completion date of March 17, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation indicated for this award. Amerisourcebergen holds a...
- The Defense Logistics Agency awarded a $6,814.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of TECVAYLI 153 mg/1.7 ml vials. This is a non-set-aside competitive award with a completion date of January 29, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving critical federal medical...
- This federal contract award, valued at $2,283.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tecvayli 30 mg/3 ml vials, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of February 7, 2025 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TECVAYLI 30 MG/3 ML VIAL 3ML, a pharmaceutical product. The contract has a ceiling value of $3,479.73 and is a Firm Fixed Price Delivery Order with a period of performance through June 20, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TECVAYLI 153 mg/1.7 ml vials valued at $11,868.12 on July 29, 2025, with a completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. TECVAYLI is a specialty pharmaceutical product reflecting the Defense Logistics Agency's ongoing procurement of specialized...
- The Defense Logistics Agency (DLA) awarded a $20,418.90 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Talvey 40 mg/mL vial. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The Defense Logistics Agency awarded a $7,299.02 delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Tevimbra 100 mg/10 mL vials. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's corporate headquarters location in...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $12,345.34 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The contract, which has a completion date of March 12, 2024, is for the provision of 120 capsules of the pharmaceutical product VYNDAQEL 20 MG. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,036.36 to AmerisourceBergen Drug Corp for TALVEY 40 mg/ml vials, with an ultimate completion date of December 30, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement executed on December 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement serving military...